9. Consolidated Financial Highlights
The following is a schedule of consolidated financial
highlights for the nine months ended September 30, 2026 and 2025. The per share data has been derived from information provided in the
consolidated financial statements.
| | |
For the nine months ended September 30, | |
| | |
2026 (Unaudited) | | |
2025 (Unaudited) | |
| Per Common Share Operating Performance | |
| | |
| |
| Net Asset Value, Beginning of Period | |
$ | 1,017.15 | | |
$ | 1,006.39 | |
| | |
| | | |
| | |
| Results of Operations: | |
| | | |
| | |
| Net Investment Income/(Loss)(1) | |
| 47.76 | | |
| 41.76 | |
| Net Realized Gains/(Losses) and Unrealized Appreciation/(Depreciation) | |
| 1.74 | | |
| 7.34 | |
| Net Increase/(Decrease) in Net Assets Resulting from Operations | |
| 49.50 | | |
| 49.10 | |
| | |
| | | |
| | |
| Distributions to Common Stockholders | |
| | | |
| | |
| Distributions from Net Investment Income | |
| (35.57 | ) | |
| (31.01 | ) |
| Net Decrease in Net Assets Resulting from Distributions | |
| (35.57 | ) | |
| (31.01 | ) |
| | |
| | | |
| | |
| Capital Share Transactions | |
| | | |
| | |
| Issuance of Common Stock | |
| - | | |
| (0.08 | ) |
| Net Increase/(Decrease) Resulting from Capital Share Transactions | |
| - | | |
| (0.08 | ) |
| | |
| | | |
| | |
| Net Asset Value, End of Period | |
$ | 1,031.08 | | |
$ | 1,024.40 | |
| | |
| | | |
| | |
| Shares Outstanding, End of Period | |
| 100,003.89 | | |
| 94,605.04 | |
| | |
| | | |
| | |
| Ratio/Supplemental Data | |
| | | |
| | |
| Net assets, end of period | |
$ | 103,111,848 | | |
$ | 96,913,420 | |
| Weighted average shares outstanding(2) | |
| 98,174.78 | | |
| 94,433.73 | |
| Total Return(3) | |
| 4.91 | % | |
| 4.90 | % |
| Portfolio turnover(4) | |
| 30.55 | % | |
| 32.94 | % |
| Ratio of total expenses to average net assets with reimbursement(5) | |
| 2.39 | % | |
| 2.84 | % |
| Ratio of total expenses to average net assets without reimbursement(5) | |
| 2.69 | % | |
| 2.84 | % |
| Ratio of net investment income/(loss) to average net assets with reimbursement(5) | |
| 6.28 | % | |
| 5.52 | % |
| (1) | The per common share data was derived using weighted average
shares outstanding during the respective period. |
| (2) | Calculated for the nine months ended September 30, 2026 and
2025, respectively. |
| (3) | Total return is based upon the change in NAV per share between
the opening and ending NAVs per share and the issuance of common stock during the respective period, and reflects reinvestment of any
distributions to common stockholders. Total returns for periods of less than 12 months are not annualized and do not include a sales
load. |
| (4) | Portfolio turnover is not an annualized amount. |
| (5) | The ratios reflect an annualized amount. |
|